Flagship explainer

What drives KEROS THERAPEUTICS, INC.’s return on equity?

ROE is five filed business factors multiplied together.

DuPont return on equity factor treeReturn on equity branches into tax burden, interest burden, operating margin, asset turnover, and the equity multiplier.Return on equity20%Tax burden95%net income ÷ pretax incomeInterest burden136%pretax ÷ operating incomeOperating margin28%operating income ÷ revenueAsset turnover0.51×revenue ÷ average assetsEquity multiplier1.09×average assets ÷ average equityAs of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com
DuPont source inputs
InputValueFiscal yearSource
$87MFY2025
Income before tax$91.9MFY2025
Operating income$67.6MFY2025
$244MFY2025
Ending assets$338MFY2025
Beginning assets$616MFY2024
$303MFY2025
$572MFY2024
Source: · event Dec 31, 2025 · retrieved Sep 4, 2026 · annual-row source set
Embed this chart

View the full KEROS THERAPEUTICS, INC. analysis at Buy Like Buffett